
    
      CONFIRM2 is a retrospective and prospective, open-label, international, multicenter
      observational registry designed to evaluate associations between CCTA imaging findings and
      clinical presentation (cross-sectional) and their ability to predict mortality and major
      adverse cardiac events (longitudinal) in patients with chronic CAD.
    
  